Exelixis Inc. (EXEL)
NASDAQ · Healthcare
Exelixis Inc. Income Statement 2009–2026
| Jan 2026 | Jan 2025 | Dec 2023 | Dec 2022 | Dec 2021 | Jan 2021 | Jan 2020 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2016 | Jan 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||||
| Revenue | 2.32B | 2.17B | 1.83B | 1.61B | 1.43B | 987.5M | 967.8M | 853.8M | 452.5M | 191.5M | 191.5M | 37.2M | 37.2M | 25.1M | 31.3M | 47.5M | 289.6M | 185.0M | 151.8M |
| Gross Profit | 2.24B | 2.09B | 1.76B | 1.55B | 1.38B | 951.3M | 934.7M | 827.5M | 437.4M | 184.9M | 184.9M | 33.3M | 33.3M | 23.1M | 30.2M | 47.5M | 289.6M | — | — |
| Profitability | |||||||||||||||||||
| Operating Income | 872.2M | 604.6M | 170.9M | 201.5M | 286.7M | 110.1M | 369.5M | 438.9M | 165.9M | -28.1M | -28.1M | -121.4M | -121.4M | -224.5M | -200.7M | -122.4M | 89.5M | -91.4M | -121.9M |
| EBITDA | 901.2M | 633.4M | 196.6M | 222.4M | 300.3M | 119.2M | 377.8M | 443.8M | 167.1M | -27.1M | -27.1M | -120.0M | -120.0M | -222.1M | -197.6M | -116.9M | 96.4M | -80.9M | -109.3M |
| Net Income | 782.6M | 521.3M | 207.8M | 182.3M | 231.1M | 111.8M | 321.0M | 690.1M | 154.2M | -70.2M | -70.2M | -161.7M | -161.7M | -261.3M | -238.2M | -145.3M | 75.7M | -92.3M | -135.2M |
| Per Share Data | |||||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 282M | 296M | 321M | 325M | 322M | 318M | 315M | 313M | 312M | 290M | 251M | 209M | 228M | 196M | 184M | 160M | 130M | 109M | 107M |
Exelixis Inc. Income Statement — FAQ
Exelixis Inc. (EXEL) income statement over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see EXEL's income statement history?
The chart and table above show Exelixis Inc.'s income statement by year and by quarter, including the growth rate.